Molecular Partners Ag (MOLN) Times Interest Earned (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Times Interest Earned of $1195.9 for Q1 2026, up 7461.27% year-on-year from $15.82 in Q1 2025, and up 10098.95% on a QoQ basis from -$11.96 in Q4 2025.
Molecular Partners Ag (MOLN) Times Interest Earned (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Times Interest Earned for 7 consecutive years, with $1195.9 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 7461.27% year-over-year to $1195.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.15 (up 99.32% YoY) and the FY2025 annual result came in at -$11.52, up 99.29% from the prior year.
- Times Interest Earned climbed to $1195.9 in Q1 2026 per MOLN's latest filing, from -$11.96 in the prior quarter.
- Over the last five years, Times Interest Earned for MOLN reached as high as $1195.9 in Q1 2026 and fell as low as -$1432.4 in Q4 2024.
- A 5-year average of $85.88 and a median of $15.82 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned plunged 12464.67% — and 2026, when it surged 7461.27%.
- Year by year, Times Interest Earned stood at $199.59 in 2022, then sank by 105.71% to -$11.4 in 2023, then slumped by 12464.67% to -$1432.4 in 2024, then jumped by 99.16% to -$11.96 in 2025, then soared by 10098.95% to $1195.9 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $1195.9, -$11.96, and $76.39 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | 1,195.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,195.91 |
| Dec 31, 2025 | -11.96 |
| Sep 30, 2025 | 76.39 |
| Jun 30, 2025 | -4.95 |
| Mar 31, 2025 | 15.82 |
| Dec 31, 2024 | -1,432.37 |
| Sep 30, 2024 | 7.48 |
| Jun 30, 2024 | -887.56 |
| Mar 31, 2024 | 1,133.50 |
| Dec 31, 2023 | -11.40 |
| Sep 30, 2023 | 1,040.91 |
| Jun 30, 2023 | 13.32 |
| Mar 31, 2023 | 27.53 |
| Dec 31, 2022 | 199.59 |
| Sep 30, 2022 | 114.86 |
| Jun 30, 2022 | -633.00 |
| Mar 31, 2022 | 615.97 |
| Dec 31, 2021 | -113.54 |
| Sep 30, 2021 | 94.96 |
| Jun 30, 2021 | 106.12 |